What's in a name? The evolution of the nomenclature of antipsychotic drugs

Journal of Psychiatry and Neuroscience

Volumn 27, Issue 3, 2002, Pages 168-175

  King, Caroline ^a   Voruganti, Lakshmi N P ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; NEUROLEPTIC AGENT; TRANQUILIZER;

DRUG CLASSIFICATION; DRUG LABELING; DRUG NOMENCLATURE; DRUG RECEPTOR BINDING; HISTORY; PSYCHOPHARMACOTHERAPY; RECEPTOR AFFINITY; REVIEW;

ANTIPSYCHOTIC AGENTS; HUMANS; RECEPTORS, DRUG; TERMINOLOGY;

EID: 0036290050     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Contributions to psychopharmacology
2. Before they called it psychopharmacology
3. Psychopharmacology: An historical perspective
4. From chlorpromazine to tardive dyskinesia (brief history of the neuroleptics)
5. The history of the psychopharmacology of schizophrenia
6. Phenothiazine treatment in acute schizophrenia
7. History of the development of antipsychotic medication
8. Some observations on the use of tranquilizing drugs
9. Drugs and the treatment of psychiatric disorders
10. Nomenclature vs. nature
11. The classification of psychotropic drugs
12. Neurotropic drugs
13. Clozapine for the treatment-resistant schizophrenic
14. Olanzapine: A new atypical antipsychotic
15. Kritische stellungnahme zum begriff der neuroleptika (anhand von pharmakologischen und klinischen befunden mit clozapin)
16. 2 receptor occupancy profile of loxapine determined using PET
17. 3 uptake
18. Discriminative-stimulus effects of clozapine in squirrel monkeys: Comparison with conventional and novel antipsychotic drugs
19. Depressive signs and symptoms in schizophrenia: A prospective blinded trial of olanzepine and haloperidol
20. Choline-esterase inhibitors: A new class of psychotropic compounds